About

After more than 30 years of scientific research de Faire Medical AB was founded in 2021with a clear Vision uncovering the full potential of applying microbial solutions to a specific organic substrate, and a unique technology of targeting bacterial strains into functional dietary supplements

Our History

[dipi_timeline admin_label=”Timeline” _builder_version=”4.18.0″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][dipi_timeline_item admin_label=”1970-1980″ ribbon=”1970-1980″ timeline_icon=”3||divi||400″ ribbon_use_circle_border=”on” _builder_version=”4.18.0″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Early observations that farmed animals suffering from intestinal inflammations recovered from eating fermented rice bran.

[/dipi_timeline_item][dipi_timeline_item admin_label=”1990″ ribbon=”1990″ timeline_icon=”3||divi||400″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]


In late 1990s, a pro-/prebiotic dietary supplement for human uses was developed and safety studies designed as open case studies were initiated. No side effects or adverse reactions were detected as a single treatment or concomitantly with other commonly used drugs, i.e. anti-inflammatory, heart medicines, antibiotics and more.

[/dipi_timeline_item][dipi_timeline_item admin_label=”2000″ ribbon=”2000″ timeline_icon=”3||divi||400″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]


In the early 2000 catalytic targeting of consortium for preferential metabolic actions was developed.

[/dipi_timeline_item][dipi_timeline_item admin_label=”2010-2020″ ribbon=”2010-2020″ timeline_icon=”3||divi||400″ _builder_version=”4.18.0″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

First study on alcohol digestion was conducted.

[/dipi_timeline_item][dipi_timeline_item admin_label=”2020″ ribbon=”2020″ timeline_icon=”3||divi||400″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]

In 2020 an additional study on alcohol digestion and a study on Type 2 diabetes were conducted with most positive outcomes.

[/dipi_timeline_item][dipi_timeline_item admin_label=”2021″ ribbon=”2021″ timeline_icon=”3||divi||400″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]


In February 2021 de Faire Medical AB was incorporated

[/dipi_timeline_item][dipi_timeline_item admin_label=”2022″ ribbon=”2022″ timeline_icon=”3||divi||400″ _builder_version=”4.18.0″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

July 2022

Launch of Myrkl in the UK & Ireland

[/dipi_timeline_item][/dipi_timeline]